231 related articles for article (PubMed ID: 29360879)
1. Different outcome of sarcoglycan missense mutation between human and mouse.
Henriques SF; Patissier C; Bourg N; Fecchio C; Sandona D; Marsolier J; Richard I
PLoS One; 2018; 13(1):e0191274. PubMed ID: 29360879
[TBL] [Abstract][Full Text] [Related]
2. A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice.
Kobuke K; Piccolo F; Garringer KW; Moore SA; Sweezer E; Yang B; Campbell KP
Hum Mol Genet; 2008 May; 17(9):1201-13. PubMed ID: 18252746
[TBL] [Abstract][Full Text] [Related]
3. Epsilon-sarcoglycan compensates for lack of alpha-sarcoglycan in a mouse model of limb-girdle muscular dystrophy.
Imamura M; Mochizuki Y; Engvall E; Takeda S
Hum Mol Genet; 2005 Mar; 14(6):775-83. PubMed ID: 15689353
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of sarcoglycans, vinculin-talin-integrin system and filamin2 in alpha- and gamma-sarcoglycanopathy: an immunohistochemical study.
Anastasi G; Cutroneo G; Trimarchi F; Santoro G; Bruschetta D; Bramanti P; Pisani A; Favaloro A
Int J Mol Med; 2004 Dec; 14(6):989-99. PubMed ID: 15547664
[TBL] [Abstract][Full Text] [Related]
5. Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation.
Bartoli M; Gicquel E; Barrault L; Soheili T; Malissen M; Malissen B; Vincent-Lacaze N; Perez N; Udd B; Danos O; Richard I
Hum Mol Genet; 2008 May; 17(9):1214-21. PubMed ID: 18252745
[TBL] [Abstract][Full Text] [Related]
6. Sarcolemmal alpha and gamma sarcoglycan protein deficiencies in Turkish siblings with a novel missense mutation in the alpha sarcoglycan gene.
Diniz G; Tosun Yildirim H; Akinci G; Hazan F; Ozturk A; Yararbas K; Tukun A
Pediatr Neurol; 2014 Jun; 50(6):640-7. PubMed ID: 24742800
[TBL] [Abstract][Full Text] [Related]
7. Repairing folding-defective α-sarcoglycan mutants by CFTR correctors, a potential therapy for limb-girdle muscular dystrophy 2D.
Carotti M; Marsolier J; Soardi M; Bianchini E; Gomiero C; Fecchio C; Henriques SF; Betto R; Sacchetto R; Richard I; Sandonà D
Hum Mol Genet; 2018 Mar; 27(6):969-984. PubMed ID: 29351619
[TBL] [Abstract][Full Text] [Related]
8. A new evidence for the maintenance of the sarcoglycan complex in muscle sarcolemma in spite of the primary absence of delta-SG protein.
Gouveia TL; Kossugue PM; Paim JF; Zatz M; Anderson LV; Nigro V; Vainzof M
J Mol Med (Berl); 2007 Apr; 85(4):415-20. PubMed ID: 17265058
[TBL] [Abstract][Full Text] [Related]
9. Sarcoglycanopathies: can muscle immunoanalysis predict the genotype?
Klinge L; Dekomien G; Aboumousa A; Charlton R; Epplen JT; Barresi R; Bushby K; Straub V
Neuromuscul Disord; 2008 Dec; 18(12):934-41. PubMed ID: 18996010
[TBL] [Abstract][Full Text] [Related]
10. Rescue of sarcoglycan mutations by inhibition of endoplasmic reticulum quality control is associated with minimal structural modifications.
Soheili T; Gicquel E; Poupiot J; N'Guyen L; Le Roy F; Bartoli M; Richard I
Hum Mutat; 2012 Feb; 33(2):429-39. PubMed ID: 22095924
[TBL] [Abstract][Full Text] [Related]
11. Beta-sarcoglycanopathy (LGMD 2E) in a Spanish family.
Rivas E; Teijeira S; dos Santos MR; Porrit I; Leturcq F; Fernandez JM; Navarro C
Acta Myol; 2004 Dec; 23(3):159-62. PubMed ID: 15938574
[TBL] [Abstract][Full Text] [Related]
12. Identification of functional domains in sarcoglycans essential for their interaction and plasma membrane targeting.
Chen J; Shi W; Zhang Y; Sokol R; Cai H; Lun M; Moore BF; Farber MJ; Stepanchick JS; Bönnemann CG; Chan YM
Exp Cell Res; 2006 May; 312(9):1610-25. PubMed ID: 16524571
[TBL] [Abstract][Full Text] [Related]
13. Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice.
Li D; Long C; Yue Y; Duan D
Hum Mol Genet; 2009 Apr; 18(7):1209-20. PubMed ID: 19131360
[TBL] [Abstract][Full Text] [Related]
14. Beta-sarcoglycan gene mutations in Turkey.
Balci B; Wilichowski E; Haliloğlu G; Talim B; Aurino S; Kremer E; Ebinger F; Senbil N; Anlar B; Kale G; Nigro V; Topaloğlu H; Bonnemann C; Dinçer P
Acta Myol; 2004 Dec; 23(3):154-8. PubMed ID: 15938573
[TBL] [Abstract][Full Text] [Related]
15. Sarcoglycan subcomplex in normal and pathological human muscle fibers.
Anastasi G; Cutroneo G; Rizzo G; Favaloro A
Eur J Histochem; 2007; 51 Suppl 1():29-33. PubMed ID: 17703591
[TBL] [Abstract][Full Text] [Related]
16. Sarcoglycans in muscular dystrophy.
Hack AA; Groh ME; McNally EM
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
[TBL] [Abstract][Full Text] [Related]
17. The sarcoglycan complex in skeletal muscle.
Tarakci H; Berger J
Front Biosci (Landmark Ed); 2016 Jan; 21(4):744-56. PubMed ID: 26709803
[TBL] [Abstract][Full Text] [Related]
18. Gamma-sarcoglycan is required for the response of archvillin to mechanical stimulation in skeletal muscle.
Spinazzola JM; Smith TC; Liu M; Luna EJ; Barton ER
Hum Mol Genet; 2015 May; 24(9):2470-81. PubMed ID: 25605665
[TBL] [Abstract][Full Text] [Related]
19. Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping.
Gao QQ; Wyatt E; Goldstein JA; LoPresti P; Castillo LM; Gazda A; Petrossian N; Earley JU; Hadhazy M; Barefield DY; Demonbreun AR; Bönnemann C; Wolf M; McNally EM
J Clin Invest; 2015 Nov; 125(11):4186-95. PubMed ID: 26457733
[TBL] [Abstract][Full Text] [Related]
20. Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects.
Sandonà D; Betto R
Expert Rev Mol Med; 2009 Sep; 11():e28. PubMed ID: 19781108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
